BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

CAPS Rating: 3 out of 5

A biopharmaceutical company that is utilizing its licensed, owned and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties.

Featured Broker Partners


Advertisement